Last reviewed · How we verify
umbilical-cord mesenchymal stromal cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
umbilical-cord mesenchymal stromal cells (umbilical-cord mesenchymal stromal cells) — Francisco Espinoza, MD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| umbilical-cord mesenchymal stromal cells TARGET | umbilical-cord mesenchymal stromal cells | Francisco Espinoza, MD | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- umbilical-cord mesenchymal stromal cells CI watch — RSS
- umbilical-cord mesenchymal stromal cells CI watch — Atom
- umbilical-cord mesenchymal stromal cells CI watch — JSON
- umbilical-cord mesenchymal stromal cells alone — RSS
Cite this brief
Drug Landscape (2026). umbilical-cord mesenchymal stromal cells — Competitive Intelligence Brief. https://druglandscape.com/ci/umbilical-cord-mesenchymal-stromal-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab